4-HO-PiPT

Chemical compound
4-HO-PiPT
Identifiers
  • 3-{2-[(propan-2-yl)(propyl)amino]ethyl}-1H-indol-4-ol
Chemical and physical data
FormulaC16H24N2O
Molar mass260.381 g·mol−1
3D model (JSmol)
  • Interactive image
  • CC(C)N(CCC)CCc1c[NH]c2cccc(O)c21
InChI
  • InChI=1S/C16H24N2O/c1-4-9-18(12(2)3)10-8-13-11-17-14-6-5-7-15(19)16(13)14/h5-7,11-12,17,19H,4,8-10H2,1-3H3
  • Key:CUTUPKOZXNFVHK-UHFFFAOYSA-N

4-Hydroxy-N-propyl-N-isopropyltryptamine (4-HO-PiPT, Piprocin) is a substituted tryptamine derivative which is claimed to have psychedelic effects. It acts as a 5-HT2A receptor agonist, with an EC50 of 13.8 nM and an efficacy of 104.8% (vs 5-HT),[1] and has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.[2]

See also

  • 4-HO-DPT
  • 4-HO-DiPT
  • 4-HO-DSBT
  • 4-HO-EiBT
  • 4-HO-McPT
  • 4-HO-McPeT
  • 5-MeO-PiPT
  • Ebalzotan
  • Propylisopropyltryptamine

References

  1. ^ Banister S, Jorgensen W, Jinlong T. Compounds. Patent WO 2023/115167
  2. ^ Knill A, Tobias S, Matthews J, Ti L (June 2022). A Report on British Columbia's Unregulated Drug Supply. Drug checking trends across British Columbia, January to December 2021 (PDF). British Columbia Centre on Substance Use (Report).
  • v
  • t
  • e


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e